Using existing data to improve steroid treatments for patients with severe lung injury.
Emulated Target Trials of Steroids in Patients with Acute Respiratory Distress Syndrome
This study is looking at how we can use information from past patients with acute respiratory distress syndrome (ARDS) to find better treatment options that fit each person's needs, especially after what we learned during the COVID pandemic.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-11045349 on NIH RePORTER |
What this research studies
This research investigates how to better use existing data to inform treatment decisions for patients suffering from acute respiratory distress syndrome (ARDS), a serious lung condition. By employing a method called 'target trial emulation,' the study aims to analyze treatment strategies that adapt over time based on individual patient needs. It will utilize large datasets from intensive care units to explore personalized treatment approaches, potentially leading to improved outcomes for patients. The research seeks to fill knowledge gaps in ARDS care that became evident during the COVID pandemic.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with acute respiratory distress syndrome, particularly those who may benefit from steroid treatments.
Not a fit: Patients with mild respiratory issues or those not diagnosed with acute respiratory distress syndrome may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective steroid treatments for patients with ARDS, potentially reducing morbidity and mortality associated with this condition.
How similar studies have performed: Previous research has shown promise in using observational data and dynamic treatment regimes to improve patient outcomes, indicating that this approach could be effective.
Where this research is happening
Cambridge, United States
- Massachusetts Institute of Technology — Cambridge, United States (Active)
Researchers
- Principal investigator: Lehman, Li-Wei H — Massachusetts Institute of Technology
- Study coordinator: Lehman, Li-Wei H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.